A collection of lab-isolated rhizosphere bacteria and fungi with demonstrated antagonistic activity against fungal pathogens, being evaluated for suppression of Tropical Race 4 (TR4) Fusarium wilt in Musa spp. Offers potential biological control and plant growth promotion for banana cultivation.
This research program focuses on a curated set of rhizosphere bacteria and fungi isolated and maintained in-house that have previously demonstrated antagonistic activity against fungal plant pathogens. The work targets Tropical Race 4 (TR4) Fusarium wilt, one of the most devastating diseases affecting banana (Musa spp.) production worldwide. Beyond disease suppression, these microbial isolates have shown positive effects on crop growth, including increased above- and below-ground biomass and yield indicators in greenhouse and field settings compared to carrier-only controls. The program seeks to validate these microbes across a spectrum of Fusarium species and to advance them toward practical deployment in banana cultivation systems.
Key features:
This technology is at an early research and proof-of-concept stage. The isolates have demonstrated prior antagonistic activity against other fungal pathogens and have shown growth-promotion benefits in greenhouse and field-grown plants, but specific validation against TR4 in Musa spp. has not yet been completed. Near-term next steps include basic culture-based antifungal assays across a range of Fusarium species and types, followed by seedling and tissue culture disease suppression trials, and ultimately greenhouse and field-like evaluations. The investigator is actively seeking a private-sector collaborator or advisor to support an NSF PFI (Partnerships for Innovation) proposal to accelerate development.
Virginia Polytechnic Institute and State University (Virginia Tech) is a comprehensive public land‑grant research university with broad graduate and professional programs and a strong industry orientation. An adjacent research and technology park links companies with faculty, shared labs, and prototyping resources, while facilities in the National Capital Region create a direct connection to federal partners and supply‑chain collaborators. Integration with a regional health system supports clinical research and translational pathways, and the statewide extension network enables field deployment and validation with industry and communities. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, and the Department of Defense. A dedicated technology transfer office provides IP management, licensing, startup formation, and industry contracting support.